Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients
1 other identifier
observational
1,000
0 countries
N/A
Brief Summary
Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients: A Prospective Analysis of Immunoassay and Liquid Chromatography Tandem Mass Spectometry (LC/MS/MS)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2010
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2010
CompletedFirst Posted
Study publicly available on registry
January 20, 2010
CompletedStudy Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedMarch 14, 2011
March 1, 2011
4 months
January 18, 2010
March 11, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy
72 hours
Interventions
LC/MS/MS Laboratory Evaluation
Eligibility Criteria
Patients with chronic pain management with or without controlled substance therapy.
You may qualify if:
- Chronic pain management with or without controlled substance therapy.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pain Management Center of Paducahlead
- Millennium Laboratoriescollaborator
Related Publications (3)
Manchikanti L, Malla Y, Wargo BW, Fellows B. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing. Pain Physician. 2011 May-Jun;14(3):259-70.
PMID: 21587329DERIVEDManchikanti L, Malla Y, Wargo BW, Fellows B. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients. Pain Physician. 2011 Mar-Apr;14(2):175-87.
PMID: 21412372DERIVEDManchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Damron KS, McManus CD, Brandon DE. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS). Pain Physician. 2010 Jan-Feb;13(1):E1-E22.
PMID: 20119473DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laxmaiah Manchikanti, MD
Ambulatory Surgery Center, Paducah
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 18, 2010
First Posted
January 20, 2010
Study Start
February 1, 2010
Primary Completion
June 1, 2010
Study Completion
June 1, 2010
Last Updated
March 14, 2011
Record last verified: 2011-03